DOI QR코드

DOI QR Code

A Case of Lactic Acidosis Caused by Linezolid Treatment of Persistent Methicillin-Resistant Staphylococcus Aureus Bacteremia

지속적인 메티실린 내성 황색포도알균 균혈증에 대한 Linezolid 치료 중 발생한 젖산 산증 1예

  • Kim, Yu-Seok (Department of Internal Medicine, Asan Medical Center, Ulsan University College of Medicine) ;
  • Kim, Ji-Beom (Department of Internal Medicine, Asan Medical Center, Ulsan University College of Medicine) ;
  • Lee, Yu-Mi (Department of Internal Medicine, Asan Medical Center, Ulsan University College of Medicine) ;
  • Kim, Sung-Han (Department of Internal Medicine, Asan Medical Center, Ulsan University College of Medicine) ;
  • Choi, Sang-Ho (Department of Internal Medicine, Asan Medical Center, Ulsan University College of Medicine) ;
  • Woo, Jun-Hee (Department of Internal Medicine, Asan Medical Center, Ulsan University College of Medicine) ;
  • Kim, Yang-Soo (Department of Internal Medicine, Asan Medical Center, Ulsan University College of Medicine)
  • 김유석 (울산대학교 의과대학 서울아산병원 내과) ;
  • 김지범 (울산대학교 의과대학 서울아산병원 내과) ;
  • 이유미 (울산대학교 의과대학 서울아산병원 내과) ;
  • 김성한 (울산대학교 의과대학 서울아산병원 내과) ;
  • 최상호 (울산대학교 의과대학 서울아산병원 내과) ;
  • 우준희 (울산대학교 의과대학 서울아산병원 내과) ;
  • 김양수 (울산대학교 의과대학 서울아산병원 내과)
  • Published : 2012.04.01

Abstract

Linezolid is an antibiotic in the oxazolidinone family that works as a bacterial protein synthesis inhibitor. It is used for the treatment of Gram-positive, multidrug-resistant bacteria. Adverse effects of linezolid include bone marrow suppression, peripheral or optic neuropathy, and, less commonly, lactic acidosis. Lactic acidosis usually occurs as a result of cardiopulmonary failure or sepsis, but it is sometimes caused by drugs, such as linezolid, and treatment of such lactic acidosis involves cessation of the drug. We report a case of lactic acidosis caused by the use of linezolid for the treatment of persistent methicillin-resistant Staphylococcus aureus bacteremia, which occurred after endoscopic sclerotherapy of gastic varices.

위 정맥류에 대한 내시경적 경화요법 이후에 위 정맥류에 발생한 패혈성 혈전 정맥염이 원발병소인 지속적인 MRSA 균혈증에서 linezolid 사용 중에 발생한 젖산 산증 1예를 경험하였기에 보고하는 바이다.

Keywords

References

  1. Diekema DJ, Jones RN. Oxazolidinone antibiotics. Lancet 2001;358:1975-1982. https://doi.org/10.1016/S0140-6736(01)06964-1
  2. Jang HC, Kim SH, Kim KH, et al. Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem. Clin Infect Dis 2009;49:395-401. https://doi.org/10.1086/600295
  3. Beekmann SE, Gilbert DN, Polgreen PM; IDSA Emerging Infections Network. Toxicity of extended courses of linezolid: results of an Infectious Diseases Society of America Emerging Infections Network survey. Diagn Microbiol Infect Dis 2008;62:407-410. https://doi.org/10.1016/j.diagmicrobio.2008.08.009
  4. Rachoin JS, Weisberg LS, McFadden CB. Treatment of lactic acidosis: appropriate confusion. J Hosp Med 2010;5:E1-E7. https://doi.org/10.1002/jhm.840
  5. McKee EE, Ferguson M, Bentley AT, Marks TA. Inhibition of mammalian mitochondrial protein synthesis by oxazolidinones. Antimicrob Agents Chemother 2006;50:2042-2049. https://doi.org/10.1128/AAC.01411-05
  6. De Vriese AS, Coster RV, Smet J, et al. Linezolid-induced inhibition of mitochondrial protein synthesis. Clin Infect Dis 2006;42:1111-1117. https://doi.org/10.1086/501356
  7. Apodaca AA, Rakita RM. Linezolid-induced lactic acidosis. N Engl J Med 2003;348:86-87. https://doi.org/10.1056/NEJM200301023480123
  8. Fung HB, Kirschenbaum HL, Ojofeitimi BO. Linezolid: an oxazolidinone antimicrobial agent. Clin Ther 2001;23:356-391. https://doi.org/10.1016/S0149-2918(01)80043-6
  9. Garrabou G, Soriano A, Lopez S, et al. Reversible inhibition of mitochondrial protein synthesis during linezolid-related hyperlactatemia. Antimicrob Agents Chemother 2007;51:962-967. https://doi.org/10.1128/AAC.01190-06
  10. Liu C, Bayer A, Cosgrove SE, et al. Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary. Clin Infect Dis 2011;52:285-292. https://doi.org/10.1093/cid/cir034
  11. Scotton P, Fuser R, Torresan S, et al. Early linezolid-associated lactic acidosis in a patient treated for tuberculous spondylodiscitis. Infection 2008;36:387-388. https://doi.org/10.1007/s15010-008-7329-3
  12. Wiener M, Guo Y, Patel G, Fries BC. Lactic acidosis after treatment with linezolid. Infection 2007;35:278-281. https://doi.org/10.1007/s15010-007-6302-x
  13. Soriano A, Miro O, Mensa J. Mitochondrial toxicity associated with linezolid. N Engl J Med 2005;353:2305-2306. https://doi.org/10.1056/NEJM200511243532123
  14. Chung SK, Jeon JS, Noh HJ, et al. A case of lactic acidosis associated with prolonged linezolid therapy. Korean J Nephrol 2009;28:41-43.